ID   BIHi001-B-7
AC   CVCL_D6KY
DR   BioSamples; SAMEA114633138
DR   hPSCreg; BIHi001-B-7
RX   PubMed=38006677;
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 10923; SLC16A2.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C118843; Allan-Herndon-Dudley syndrome
DI   ORDO; Orphanet_59; Allan-Herndon-Dudley syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YN70 ! BIHi001-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 02-05-24; Version: 1
//
RX   PubMed=38006677; DOI=10.1016/j.scr.2023.103256;
RA   Ludwik K.A., Opitz R., Jyrch S., Megges M., Weiner J. III, Beule D.,
RA   Kuhnen P., Stachelscheid H.;
RT   "Generation of iPSC lines with SLC16A2:G401R or SLC16A2 knock out.";
RL   Stem Cell Res. 73:103256-103256(2023).
//